[1]
“Sustained virological response to treatment of chronic hepatitis C with peginterferon alfa and ribavirin”, Braz. J. Pharm. Sci., vol. 48, no. 2, pp. 193–201, Jun. 2012, doi: 10.1590/S1984-82502012000200002.